Business Description
Jiangsu Kanion Pharmaceutical Co Ltd
NAICS : 325412
No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001
Compare
Compare
Traded in other countries / regions
600557.China
Description
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.75 | |||||
Interest Coverage | 60.28 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 5.79 | |||||
Beneish M-Score | -3 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.5 | |||||
3-Year EBITDA Growth Rate | -7.4 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | 31.2 | |||||
3-Year Book Growth Rate | 4.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.39 | |||||
9-Day RSI | 45.31 | |||||
14-Day RSI | 46.98 | |||||
6-1 Month Momentum % | 44.32 | |||||
12-1 Month Momentum % | 46.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.37 | |||||
Quick Ratio | 2.15 | |||||
Cash Ratio | 0.96 | |||||
Days Inventory | 103.77 | |||||
Days Sales Outstanding | 74.92 | |||||
Days Payable | 102.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -100 | |||||
3-Year Average Share Buyback Ratio | 1.3 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.16 | |||||
Operating Margin % | 9.83 | |||||
Net Margin % | 9.36 | |||||
ROE % | 8.61 | |||||
ROA % | 6.29 | |||||
ROIC % | 10 | |||||
ROC (Joel Greenblatt) % | 12.52 | |||||
ROCE % | 8.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.17 | |||||
PE Ratio without NRI | 22.17 | |||||
Shiller PE Ratio | 21.87 | |||||
Price-to-Owner-Earnings | 51.09 | |||||
PS Ratio | 2.06 | |||||
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 2.06 | |||||
Price-to-Free-Cash-Flow | 11.52 | |||||
Price-to-Operating-Cash-Flow | 9.47 | |||||
EV-to-EBIT | 18.78 | |||||
EV-to-EBITDA | 18.78 | |||||
EV-to-Revenue | 1.85 | |||||
EV-to-FCF | 10.19 | |||||
Price-to-Projected-FCF | 1.1 | |||||
Price-to-Median-PS-Value | 0.68 | |||||
Price-to-Graham-Number | 1.43 | |||||
Price-to-Net-Current-Asset-Value | 5.82 | |||||
Earnings Yield (Greenblatt) % | 5.33 | |||||
Forward Rate of Return (Yacktman) % | -2.91 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3,976.631 | ||
EPS (TTM) (¥) | 0.65 | ||
Beta | 0.48 | ||
Volatility % | 36.75 | ||
14-Day RSI | 46.98 | ||
14-Day ATR (¥) | 0.635421 | ||
20-Day SMA (¥) | 14.451 | ||
12-1 Month Momentum % | 46.9 | ||
52-Week Range (¥) | 9.22 - 17.5 | ||
Shares Outstanding (Mil) | 576.43 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jiangsu Kanion Pharmaceutical Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |